RENAL EVENTS AMONG WOMEN TREATED WITH TENOFOVIR/EMTRICITABINE IN COMBINATION WITH EITHER LOPINAVIR/RITONAVIR OR NEVIRAPINE: ANALYSIS FROM THE AIDS CLINICAL TRIAL GROUP (ACTG) A5208 TRIAL

OBJECTIVES: Tenofovir disoproxil fumarate (TDF) has been associated with renal insufficiency. Co-administration with boosted protease inhibitors (PIs), which increases its exposure, may further increase the risk of renal insufficiency. METHODS: We compared the incidence of renal events among women t...

תיאור מלא

שמור ב:
מידע ביבליוגרפי
Main Authors: MWAFONGO, Albert, NKANAUNENA, Kondwani, ZHENG, Yu, HOGG, Evelyn, SAMANEKA, Wadzanai, MULENGA, Lloyd, SIIKA, Abraham, CURRIER, Judith, LOCKMAN, Shahin, HUGHES, Michael D., HOSSEINIPOUR, Mina
פורמט: Artigo
שפה:Inglês
יצא לאור: 2014
נושאים:
Article
גישה מקוונת:https://ncbi.nlm.nih.gov/pmc/articles/PMC4176616/
https://ncbi.nlm.nih.gov/pubmed/24445367
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/QAD.0000000000000202
תגים: הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!

פריטים דומים